| James P Cole, BS | |
|
601 John St, M273, Kalamazoo, MI 49007-5341 | |
| (269) 381-0180 | |
| (269) 381-7347 |
| Full Name | James P Cole |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 19 Years |
| Location | 601 John St, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518052067 | NPI | - | NPPES |
| 640C903140 | Other | MI | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 147000875 (Illinois) | Secondary |
| 231H00000X | Audiologist | 1601000568 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hearing Specialists Of Kalamazoo Inc | 8921267840 | 2 |
News Archive
IsoRay, Inc. announced today that it has successfully shipped the first set of Cesium-131 brachytherapy seeds to a Canadian customer for the purpose of furthering research and development of Cesium-131 in Canada. Cesium-131 is currently approved by Health Canada for the treatment of low-risk prostate cancers and has been cleared by the US FDA for treatment of a wide variety of malignant disease (e.g. prostate, head and neck, brain, breast, lung, eye, etc.).
Researchers have zoomed in on mouse chromosomes to map hotspots of genetic recombination - sites where DNA breaks and reforms to shuffle genes. The findings of the scientists at the National Institutes of Health and Uniformed Services University of Health Sciences (USU) have the potential to improve the detection of genes linked to disease and to help understand the root causes of genetic abnormalities.
A large study of intensive care patients in California found that public reporting of patient outcomes did not reduce mortality, but did result in reduced admission of the sickest patients to the ICU and increased transfer of critically ill patients to other hospitals.
On the eve of World Health Day 2011, Inter Press Service examines the growing global challenge of antibimicrobial resistance.
› Verified 5 days ago
| Provider Name | Bronson Methodist Hospital |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
IsoRay, Inc. announced today that it has successfully shipped the first set of Cesium-131 brachytherapy seeds to a Canadian customer for the purpose of furthering research and development of Cesium-131 in Canada. Cesium-131 is currently approved by Health Canada for the treatment of low-risk prostate cancers and has been cleared by the US FDA for treatment of a wide variety of malignant disease (e.g. prostate, head and neck, brain, breast, lung, eye, etc.).
Researchers have zoomed in on mouse chromosomes to map hotspots of genetic recombination - sites where DNA breaks and reforms to shuffle genes. The findings of the scientists at the National Institutes of Health and Uniformed Services University of Health Sciences (USU) have the potential to improve the detection of genes linked to disease and to help understand the root causes of genetic abnormalities.
A large study of intensive care patients in California found that public reporting of patient outcomes did not reduce mortality, but did result in reduced admission of the sickest patients to the ICU and increased transfer of critically ill patients to other hospitals.
On the eve of World Health Day 2011, Inter Press Service examines the growing global challenge of antibimicrobial resistance.
› Verified 5 days ago
| Provider Name | Hearing Specialists Of Kalamazoo Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073763108 PECOS PAC ID: 8921267840 Enrollment ID: O20120313000803 |
News Archive
IsoRay, Inc. announced today that it has successfully shipped the first set of Cesium-131 brachytherapy seeds to a Canadian customer for the purpose of furthering research and development of Cesium-131 in Canada. Cesium-131 is currently approved by Health Canada for the treatment of low-risk prostate cancers and has been cleared by the US FDA for treatment of a wide variety of malignant disease (e.g. prostate, head and neck, brain, breast, lung, eye, etc.).
Researchers have zoomed in on mouse chromosomes to map hotspots of genetic recombination - sites where DNA breaks and reforms to shuffle genes. The findings of the scientists at the National Institutes of Health and Uniformed Services University of Health Sciences (USU) have the potential to improve the detection of genes linked to disease and to help understand the root causes of genetic abnormalities.
A large study of intensive care patients in California found that public reporting of patient outcomes did not reduce mortality, but did result in reduced admission of the sickest patients to the ICU and increased transfer of critically ill patients to other hospitals.
On the eve of World Health Day 2011, Inter Press Service examines the growing global challenge of antibimicrobial resistance.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James P Cole, BS 601 John St, Suite M273, Kalamazoo, MI 49007-5341 Ph: (269) 381-0180 | James P Cole, BS 601 John St, M273, Kalamazoo, MI 49007-5341 Ph: (269) 381-0180 |
News Archive
IsoRay, Inc. announced today that it has successfully shipped the first set of Cesium-131 brachytherapy seeds to a Canadian customer for the purpose of furthering research and development of Cesium-131 in Canada. Cesium-131 is currently approved by Health Canada for the treatment of low-risk prostate cancers and has been cleared by the US FDA for treatment of a wide variety of malignant disease (e.g. prostate, head and neck, brain, breast, lung, eye, etc.).
Researchers have zoomed in on mouse chromosomes to map hotspots of genetic recombination - sites where DNA breaks and reforms to shuffle genes. The findings of the scientists at the National Institutes of Health and Uniformed Services University of Health Sciences (USU) have the potential to improve the detection of genes linked to disease and to help understand the root causes of genetic abnormalities.
A large study of intensive care patients in California found that public reporting of patient outcomes did not reduce mortality, but did result in reduced admission of the sickest patients to the ICU and increased transfer of critically ill patients to other hospitals.
On the eve of World Health Day 2011, Inter Press Service examines the growing global challenge of antibimicrobial resistance.
› Verified 5 days ago
Scott Andrew Hansson, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Oakland Dr, Kalamazoo, MI 49008 Phone: 269-387-7000 | |
Nancy Ann Gallihugh, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1634 Gull Rd, Kalamazoo, MI 49048 Phone: 269-343-2601 | |
Ms. Teresa B Crumpton, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1000 Oakland Dr Fl 3, Kalamazoo, MI 49008 Phone: 269-387-7000 Fax: 269-387-7026 | |
Dr. Mary Elizabeth Peterson, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Oakland Dr Fl 3, Wmu Unified Clinics Charles Van Riper Language Speech, Kalamazoo, MI 49008 Phone: 269-387-7209 Fax: 269-387-7227 | |
Kathryn Louise Hamann, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1634 Gull Rd, Kalamazoo, MI 49048 Phone: 269-343-2601 | |
Kimberly Anne Kragt, MA, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1634 Gull Rd Lowr 201, Kalamazoo, MI 49048 Phone: 269-343-2601 | |
Sandra Almlie, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1634 Gull Rd, Suite 201, Kalamazoo, MI 49048 Phone: 269-343-2601 Fax: 269-343-9257 |